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Human genetic factors predispose to tuberculosis (TB). We studied 7.6 million genetic variants in 
5,530 pulmonary TB patients and 5,607 healthy controls. In the combined analysis of these 
subjects and the follow-up cohort (15,087 TB patients and controls altogether), we found 
association between TB and variants located in introns of the ASAP1 gene on chromosome 8q24 
(P = 2.6 × 10−11 for rs4733781; P = 1.0 × 10−10 for rs10956514). Dendritic cells (DCs) showed 
high level of ASAP1 expression, which was reduced after M. tuberculosis infection, and 
rs10956514 was associated with the level of reduction of ASAP1 expression. The ASAP1 protein 
is involved in actin and membrane remodeling and has been associated with podosomes. The 
ASAP1-depleted DCs showed impaired matrix degradation and migration. Therefore, genetically 
determined excessive reduction of ASAP1 expression in M. tuberculosis-infected DCs may lead to 
their impaired migration, suggesting a potential novel mechanism that predisposes to TB.
Introduction
Tuberculosis (TB) is a major public health problem in the developing world and an 
increasing threat in developed countries1. While 2 billion people are estimated to be infected 
with the TB pathogen, Mycobacterium tuberculosis, only ~10% of infected individuals 
eventually develop active TB1. A majority can contain the pathogen; the infection remains 
latent and clinical disease never occurs. Case observations, twin studies and mouse models 
indicate that host genetic factors are important in determining susceptibility to M. 
tuberculosis2,3. Recent genome wide association studies (GWAS) reported two loci on 
chromosomes 11p13 and 18q11 that contain single nucleotide polymorphisms (SNPs) 
associated with TB4,5. However, the pathophysiological mechanisms underpinning these 
genetic associations remain unknown.
Results
Genome-wide association study
To identify novel genes associated with susceptibility to TB, we initially studied 5,914 HIV-
negative patients with active pulmonary TB confirmed by culture of M. tuberculosis from 
sputum, as well as 6,022 healthy adult controls from Russia (see Methods). We genotyped 
their DNA samples using Affymetrix Genome-Wide Human SNP Array 6.0. After rigorous 
quality control procedures (Methods, Supplementary Figs. 1 and 2) 5,530 TB patients and 
5,607 controls with high quality genotypes at 707,452 SNPs remained (Set 1). We then 
imputed genotypes at 7,614,862 SNPs into the Set 1 subjects using data from the 1000 
Genomes project. We tested these SNPs for association with TB using logistic regression 
corrected for 4 principal components, and did not observe significant inflation of test 
statistics (λGC = 1.10), indicating that our cases and controls are well matched 
(Supplementary Fig. 3).
We first examined our association results in the context of previously published TB GWAS 
in two African populations4,5. We did not detect any association at the previously reported 
18q11 locus. However, we did see association at the 11p13 locus (rs2057178, P = 0.00068, 
Supplementary Table 1), as we reported previously for the overlapping Russian dataset5. 
This is also consistent with another recently published TB GWAS in the South African 
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population6 and suggests that the 11p13 locus is associated with TB risk in various 
populations, whereas the 18q11 locus may be population-specific. We next studied 
candidate genes previously reported to be associated with TB and found weak signals in 
several genes, including the HLA-DQA1 region (Supplementary Table 2). We then looked 
for the overlap with published genetic associations in another human mycobacterial 
infectious disease, leprosy7,8, and in inflammatory bowel disease (IBD) that is known to be 
enriched with genes involved in defense against mycobacteria9. We found that, except for 
the MHC region, none of those loci was significantly associated with TB after Bonferroni 
correction (Supplementary Tables 3 and 4).
Our only genome-wide significant TB-associated locus was on chromosome 8q24, where 11 
SNPs located in introns of the ASAP1 gene had P < 5 × 10−8 (Fig. 1); the strongest 
association was at rs2033059 (P = 1.1 × 10−8). To rule out possible technical artefacts, and 
to attempt to replicate our discovery, we designed individual Taqman genotyping assays for 
seven out of the most significantly associated ASAP1 SNPs. We genotyped these SNPs in 
Set 1 and, additionally, in 1,085 pulmonary TB patients and 2,865 controls from Russia (Set 
2). In the combined analysis of 15,087 subjects in Sets 1 and 2 all seven SNPs showed 
convincing evidence of association with TB (Table 1); the most significant association was 
at rs4733781 (P = 2.6 × 10−11). In order to try to identify which of these seven SNPs is 
likely the functional polymorphism affecting risk to pulmonary TB, we employed a 
Bayesian fine-mapping approach (Methods). Three SNPs had less than 5% posterior 
probability of being causal, leaving four likely candidates (Table 1), with rs4733781 having 
the highest posterior (43.6%). This narrowing to four candidates likely represents the limit 
of genetic resolution in our Russian dataset.
We then analyzed the seven ASAP1 SNPs in the Ghanaian (971 TB cases and 988 controls) 
and Gambian (1,306 TB cases and 1,372 controls) GWAS datasets that were published 
previously4,5 (Table 2). Despite that these SNPs were less frequent in the African 
populations than in Russians, resulting in lower statistical power to detect association, this 
analysis provided further support for TB association of the ASAP1 SNPs, e.g. for rs4733781 
effects in the Ghanaian and Gambian datasets were similar to those in the Russian dataset 
(ORs = 0.89, 0.89 and 0.84, respectively; PGhana+Gambia = 0.052 and the overall 
PRussia+Ghana+Gambia = 3.6 × 10−12).
Analyses of ASAP1 expression and function
The ASAP1 gene (also known as AMAP1 or DDEF1) encodes an Arf GTPase-activating 
protein (Arf GAP), a multifunctional scaffold protein that induces hydrolysis of GTP bound 
to the ADP ribosylation factor family GTP-binding (Arf) proteins10. The Arf and Arf GAP 
proteins are known to regulate coordinated actin and membrane remodelling11. In NIH 3T3 
fibroblasts localization of the ASAP1 protein was associated with focal adhesions, circular 
dorsal ruffles, podosomes and invadopodia, i.e. large macromolecular complexes that 
connect intracellular actin cytoskeleton to the extracellular matrix and are important for cell 
adhesion and migration, as well as invasion of cancer cells11. The transition of a cell from a 
quiescent to a migratory phenotype is characterized by the dissolution of focal adhesions and 
the formation of podosomes or invadopodia at the sites of contact with extracellular 
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matrix12. In vitro knockdown and reduction of ASAP1 expression in the transformed 
fibroblast and prostate cancer cell lines has been shown to prevent formation of invadopodia 
and suppress cell migration and invasiveness13,14. Overexpression of ASAP1 has been 
associated with metastasis in several cancers14-17. While invadopodia are found in 
transformed cells, podosomes are similar structures that are present in several types of 
normal cells, including macrophages and dendritic cells (DCs)12. These immune cells play 
critical roles in TB pathogenesis. Thus, the infection is initiated when inhaled M. 
tuberculosis bacilli are phagocytosed by alveolar macrophages, which provide a cellular 
niche for the expansion of mycobacteria. The onset of adaptive immune response leads to 
killing of mycobacteria and sterilization of regional lesions18. DCs are crucial for the 
initiation of the adaptive immunity: infected DCs migrate to the lung-draining lymph nodes 
and activate T cells19. M. tuberculosis is known to inhibit migration as well as other 
functions of DCs, and the adaptive immunity in TB is delayed compared with other 
microbial infections20-22.
The role of ASAP1 in macrophages, DCs and other immune cells has not been studied 
previously. To investigate it, we initially characterized the ASAP1 mRNA expression by 
quantitative reverse transcriptase-PCR (qRT-PCR) in primary leukocytes of healthy donors 
and found that monocytes, B lymphocytes, CD4+ and CD8+ T lymphocytes and neutrophils 
express relatively low levels of ASAP1. However, when monocytes were differentiated into 
macrophages or DCs, the expression of ASAP1 increased (Fig. 2a). We then infected DCs 
with Mycobacterium bovis BCG and found that it led to the reduction of ASAP1 expression 
(Fig. 2a). We also analyzed ASAP1 expression in DCs from 65 subjects that were previously 
studied using microarrays23. Similar to our results, in this dataset the ASAP1 level in the M. 
tuberculosis-infected DCs was significantly lower than in non-infected DCs (log2 fold 
change = −0.49, Pcorrected = 2.9 × 10−18, ref 23). To study if any of the TB-associated SNPs 
in the ASAP1 gene affects its expression, we first analyzed rs10956514 and rs4733781 that 
were genotyped in this dataset. The SNP rs10956514 showed evidence of association with 
ASAP1 expression in non-infected samples (P = 4.6 × 10−3) and with the relative level of 
reduction in ASAP1 expression after M. tuberculosis infection (P = 4.6 × 10−3). 
Homozygotes of allele A, which was associated with higher TB risk in our GWAS, showed 
stronger reduction of ASAP1 expression after infection than homozygotes of allele G, which 
was associated with lower TB risk (Fig. 2b). We imputed genotypes of other TB-associated 
ASAP1 SNPs and found that they had weaker association with the level of reduction of 
ASAP1 expression after M. tuberculosis infection than rs10956514 (Supplementary Table 5). 
The lack of association between ASAP1 expression and rs4733781 reflects different linkage 
disequilibrium patterns in this region (e.g. r2 between rs4733781 and rs10956514 was 0.8 in 
the Russian dataset, but only 0.62 in 65 non-Russian Caucasians23). These results indicate 
that larger studies in different populations will be needed to pinpoint the causative variant 
affecting ASAP1 expression, and thence the risk of pulmonary TB. Nevertheless, our results 
suggest that either rs10956514 or a polymorphism in strong linkage disequilibrium with it 
may be responsible for the control of ASAP1 expression in DCs. Since rs10956514 is also 
one of the candidates associated with the risk of active pulmonary TB (Table 1), genetically 
regulated levels of ASAP1 expression in DCs are likely to be important in TB pathogenesis.
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To investigate the role of the ASAP1 protein in DCs, we first studied its cellular 
localization. Confocal microscopy showed that the ASAP1 protein was localized in the 
cytoplasm and partly was associated with podosomes (Fig. 3a). Therefore, we hypothesized 
that reduced ASAP1 expression may affect matrix degradation by DCs and their migration. 
To test this, we isolated primary monocytes from healthy volunteers, derived DCs in vitro 
and transfected them with siRNA to reduce ASAP1 expression. We found that degradation 
of a gelatine matrix by the ASAP1-depleted DCs was impaired (Fig. 3b) and such cells 
migrated significantly slower than control cells (Fig. 3c).
Discussion
Taken together, our results suggest that impaired migration of M. tuberculosis-infected DCs, 
caused by the genetically determined excessive reduction of ASAP1 expression, may 
contribute to TB pathogenesis. It may be one of the mechanisms that lead to the slow 
migration of DCs to lymph nodes and delay the adaptive immune response during early 
stages of TB infection. Furthermore, given that latent TB is a state of dynamic equilibrium, 
it is likely that trafficking of immune cells in granulomas has to be constantly maintained19. 
Therefore, impaired migration of DCs and/or macrophages due to the reduced ASAP1 
expression may contribute also at late stages of infection leading to reactivation of latent TB.
To date, GWAS of susceptibility to TB and other infectious diseases identified fewer 
associated loci than studies of other complex diseases. This indicates that effects of common 
polymorphisms predisposing to infection are usually small, and current GWA studies may 
be statistically underpowered. In TB, this can be explained by the strong selective pressure 
exerted by M. tuberculosis, an ancient and wide-spread pathogen. Nevertheless, our results 
demonstrate that when associated variants are found, they can highlight novel molecular 
mechanisms implicated in infection and host responses. Future studies will further clarify 
how the ASAP1-mediated pathways are involved in mycobacterial infection and predispose 
to TB.
Online Methods
Ethics
Blood samples from all participants have been collected and studied with the written 
informed consent according to the Declaration of Helsinki and with approvals from the local 
Ethics Committees in Russia (St. Petersburg and Samara), and the UK (Human Biological 
Resource Ethics Committee of the University of Cambridge and the National Research 
Ethics Service Cambridgeshire 1 REC, ref 10/H0304/71).
TB patients and controls
Pulmonary TB patients attending civilian TB dispensaries and TB clinics along with healthy 
subjects attending the blood transfusion service were recruited in two Russian cities, St. 
Petersburg and Samara, as described previously24. TB patients have been diagnosed using 
information about TB contact, medical history and clinical symptoms (cough, haemoptysis, 
chest pain, fever, weight loss), presence of acid fast bacilli in sputum smear and symptoms 
characteristic of pulmonary TB on chest X rays. For all patients in this study diagnosis has 
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been confirmed by culture of M. tuberculosis from sputum; otherwise patients were 
excluded. We also excluded from the study patients with extra-pulmonary TB and all HIV-
positive subjects. Controls were healthy adult blood bank donors with no history of TB. M. 
tuberculosis infection status of these controls was unknown. We studied genotypes of 
15,087 subjects, including 6,615 TB patients (4,074 from St. Petersburg and 2,541 from 
Samara) and 8,472 controls (5,555 from St. Petersburg and 2,917 from Samara). Average 
age was 45 years for patients and 31 years for controls. There were 73% of males among 
patients and 71% of males among controls. This sample size provides >80% statistical 
power to detect association with P = 5 × 10−8 for polymorphisms with minor allele 
frequencies (MAF) > 20% and OR > 1.2.
Genotyping, quality control and association analyses
We extracted genomic DNA from whole blood of the participating subjects using a standard 
chloroform/proteinase K protocol. We checked DNA quality using 1% agarose gel 
electrophoresis, determined DNA concentration using Picogreen assay and then normalized 
concentration for genotyping.
In GWAS, genotyping was done using the Affymetrix Genome-Wide Human SNP Array 
6.0. Genotypes were called in 5,914 TB cases and 6,022 controls using Birdseed25. 
Individuals were excluded if they had more than 2% missing genotype data or showed 
excess of heterozygous genotypes (±3.5 standard deviations, Supplementary Fig. 1). For 
each pair of individuals, we calculated identity-by-state (IBS) and excluded samples with 
IBS > 80% as likely duplicates or close relatives. Finally, IBS was also calculated between 
each sample from this study and 1,397 samples from the International HapMap project. The 
IBS relationships were converted to distance, and projected onto two axes of 
multidimensional scaling. We removed non-European ancestry outliers based on these 
projections (Supplementary Fig. 2a). After removing these individuals, we excluded SNPs 
with a call rate of less than 98%, Hardy-Weinberg P-value < 10−6 (in controls), missing rate 
per SNP difference in cases and controls > 0.02 or a minor allele frequency less than 1%. In 
total, 799 individuals and 175,385 SNPs were excluded, leaving for analysis 707,452 SNPs 
in 5,530 cases and 5,607 controls, which we call Set 1. Principal component analysis was 
performed across autosomal SNPs within Set 1 (Supplementary Figs. 2b and 2c). We 
computed the first 10 principal components and decided to include the top 4 in our 
downstream analysis to account for population structure remaining in our dataset.
We imputed SNPs from the 1000 Genomes Phase I (interim) release into our Set 1 samples 
using IMPUTE226,27. Imputed SNPs were excluded if the imputation quality score r2 was < 
0.5 and minor allele frequency was < 1%. After filtering, 7,614,862 SNPs were left for 
further association analyses.
TB association was tested with logistic regression implemented in SNPTEST28 on genotype 
likelihoods from imputation, with 4 PCs as covariates. The genomic control inflation factor 
λGC for SNPs before and after imputation was 1.10 (Supplementary Fig. 3), indicating that 
we have successfully controlled for any residual population structure between cases and 
controls.
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SNPs from the 1000 Genomes Phase I (interim) release were imputed into Ghanaian and 
Gambian subjects using IMPUTE2 and TB association of the seven ASAP1 SNPs was tested 
with logistic regression implemented in SNPTEST.
We genotyped seven ASAP1 SNPs using custom Taqman assays (Supplementary Table 6) 
and 7900HT system from Applied Biosystems. We visually checked all genotype clusters, 
assigned calls and extracted genotypes using SDS 2.3 software. TB association was tested in 
STATA11 using logistic regression, with the city of the sample origin (St. Petersburg or 
Samara) as a covariate.
To conduct Bayesian fine-mapping we calculated marginal likelihoods for each SNP and 
Bayes Factors using a normal prior with mean 0 and variance 0.2. Posterior probabilities 
were assigned using the relative contribution of each SNP’s Bayes Factor to the sum of 
Bayes Factors across all seven SNPs29.
We analyzed the seven ASAP1 SNPs in the Ghanaian and Gambian TB GWAS datasets that 
were published previously4,5. The Gambian dataset is available in the The European 
Genome-phenome Archive (accession number EGAS00000000027). Both Ghanaian and 
Gambian datasets have been QCed by filtering individuals with discordant sex information, 
elevated missing data rates (>2%), outlying heterozygosity rate (±3.5 standard deviations), 
duplicated or related individuals with IBS >80% and divergent ancestry based on principal 
component projections using the HapMap dataset. In total, 101 (13 cases and 88 controls) 
and 316 (192 cases and 124 controls) individuals were excluded from Ghanaian and 
Gambian datasets, respectively. After individual quality control, we imputed the seven 
ASAP1 SNPs from the 1000 Genomes Phase I (interim) release into Ghanaian and Gambian 
samples using IMPUTE226,27.
Analysis of association between SNPs and levels of ASAP1 mRNA expression in DCs
We analyzed genome-wide expression data from DCs isolated from 65 Caucasian 
subjects23. These DCs were either non-infected or infected in vitro for 18 hours with M. 
tuberculosis and were studied using Illumina HT-12 expression arrays23. The raw data can 
be obtained from the GEO database (accession numbers GSE34588 and GSE34151). For our 
analysis, we used a cleaned dataset provided by L. Barreiro (personal communications) in 
which expression levels were regressed using the first 5 principal components for the data 
from non-infected cells and the first 8 principal components for the data from infected cells. 
We used the R package snpStats (D. Clayton, snpStats: snpMatrix and XSnpMatrix classes 
and methods, R package version 1.12.10) to fit generalized linear models, with SNP 
genotypes as predictor variables and expression levels of ASAP1 as responses. We report P-
values for the two-tailed test where the null hypothesis was that the true value of the 
generalized linear model coefficient is zero. We imputed genotypes of the ASAP1 SNPs 
rs2033059, rs17285138, rs1469288, rs12680942, rs1017281 with the MaCH and minimac 
software packages30 using genotype data from 1000 Genomes.
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Cells and Antibodies
Human PBMC were isolated from fresh peripheral blood of healthy adult volunteers 
participating in the Cambridge BioResource cohort by centrifugation of peripheral blood 
with a gradient of Ficoll-paque Plus (GE Healthcare) at 860 g for 23 minutes at room 
temperature. Buffy coat layer containing PBMC was used for sequential isolation of 
monocytes, CD8+ T cells, CD4+ T cells and B cells. Red blood cells (RBCs) and 
polymorphonuclear cells sediment was used for neutrophil isolation. Monocytes were 
purified from PBMC using the MACS CD14+ Isolation kit (Miltenyi, UK Cat. No 
130-050-201). CD8+ and CD4+ T cells were isolated from PBMCs using immunomagnetic 
positive selection kits (Stemcells Technologies Cat. No. 18053 and 18052). B cells were 
isolated from PBMCs using an immunomagnetic negative selection kit (Miltenyi Biotec 
130-091-151). To isolate neutrophils, RBCs and granulocytes sediments were incubated 
with the same volume of fresh cold RBC lysis buffer on ice for 30 minutes and centrifuged 
for 5 minutes at 200 g. Cell pellets were then suspended with 10 ml of cold RBC lysis buffer 
and incubated on ice for 10 minutes. Neutrophil pellets were then washed with cold PBS 3 
times.
To derive dendritic cells (DCs), the monocytes were cultured for 6 days in RPMI-1640 (Life 
technologies) with gentamycin (50 μg/ml), 5% FCS, GM-CSF (50 U/ml, Miltenyi, UK) and 
IL-4 (1000 U/ml, R&D Systems). To derive macrophages, the monocytes were cultured for 
5 days in RPMI-1640 with HEPES (0.02 M), gentamycin (50 μg/ml), 10% FCS and 50 
ng/ml M-CSF (Miltenyi, UK). Where indicated DCs were infected with live M. bovis BCG 
genetically modified to express mCherry protein (provided by Dr Brian Robertson, Imperial 
College, UK) at multiplicity of infection 3:1 and then lysed for RNA or protein extraction.
For immunofluorescence the following antibodies were used: anti-ASAP1 antibody 
(Sc-81896, Santa Cruz Biotechnology), anti-Vinculin antibody (700062, Invitrogen) and 
Alexa Fluor 568-coupled phalloidin (A12380, Molecular Probes). The secondary antibodies 
were Alexa Fluor 633-conjugated goat anti-rabbit IgG (Molecular Probes), and Alexa Fluor 
488-conjugated donkey anti-mouse IgG (Molecular Probes). For western blots the following 
antibodies were used: anti-ASAP1 antibody (ab11011, Abcam) and anti-Actin antibody 
(A5441, Sigma).
qRT-PCR
Two-step qRT-PCR was used for analysis of the ASAP1 mRNA expression in neutrophils, 
monocytes, CD4+ T cells, CD8+ T cells, B cells, monocyte-derived macrophages and 
monocyte-derived DCs. Total RNA was isolated from cells using Isolate RNA Mini Kit as 
per the manufacturer’s instructions (Bioline UK, Cat No: BIO-52044). Then the first strand 
cDNA was generated from 200 ng of total RNA using Thermo Scientific Maxima Reverse 
Transcriptase (Thermo Scientific, UK, Cat. No. EP0741) and diluted 1:5. Then 2 μl were 
taken for qPCR using KAPA SYBR FAST Universal qPCR kit (Kapa Biosystems, UK, Cat. 
No. KK4602), ASAP1 primers and primers for the beta-2 microglobulin gene 
(Supplementary Table 7). qPCR reactions were done in triplicate. The data were analyzed 
using delta Ct values, providing ASAP1 mRNA expression levels relative to the levels of 
beta-2 microglobulin mRNA.
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siRNA transfection
DCs were transfected at day 1 and day 4 using Hiperfect (Qiagen) with either a pool of three 
ASAP1-specific siRNAs (Supplementary Table 7) or with a control, scrambled, siRNA 
(1027281, Qiagen). Western blotting with the anti-ASAP1 antibody (ab11011, Abcam) was 
done in each case to assess knockdown efficiency. Results were analysed only if in cells 
treated with the ASAP1 siRNA expression of the ASAP1 protein was reduced to below 60% 
of that in cells treated with the control siRNA.
DC matrix degradation assay
Cover slips were coated with 0.2 mg/ml FITC-coupled gelatine (G13187, Molecular Probes) 
and subsequently blocked using complete media. The siRNA-treated cells were seeded on 
the cover slips and incubated at 37°C for 4 hours and fixed with 4% PFA. The cells were 
labelled with Alexa Fluor 568-coupled phalloidin (A12380, Molecular Probes) and mounted 
in anti-fade with DAPI (P36931, Molecular Probes). Cells were imaged on a Leica SP5 
confocal microscope. The images were processed using ImageJ (Wayne Rasband, NIH). 
Matrix degradation was quantified by measuring the area where the FITC labelled-gelatine 
was below the threshold and counting the number of cells using ImageJ, as described 
before31.
DC migration assay
The siRNA-treated cells were seeded on cover slips coated with 0.025 mg/ml fibronectin 
(F1141, Sigma) and incubated at 37°C for 4 hours in their usual media without GM-CSF or 
IL-4. Cover slips were then inverted onto Dunn chambers containing GM-CSF (100 U/ml). 
The cells were imaged every 2-4 minutes for a minimum of 2 hours in the 37°C chamber of 
Leica SPE. Images were processed and analyzed using the manual track plugin of ImageJ 
and velocity was calculated.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Genome-wide association study of susceptibility to TB
(a) Manhattan plot showing TB association of genotyped and imputed SNPs across the 
genome. SNPs with P < 5 × 10−8 are shown in red.
(b) Regional plot showing SNPs in the ASAP1 gene region. Circles show P-values obtained 
in GWAS in Set 1; diamonds show P-values obtained in the follow-up study of 7 SNPs in 
Sets 1 and 2 combined. Horizontal line corresponds to P < 5 × 10−8. Colors indicate linkage 
disequilibrium (r2) between the most-associated SNP rs4733781 and other SNPs.
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Figure 2. ASAP1 expression in peripheral blood leukocytes and monocyte-derived macrophages 
and dendritic cells (DCs)
(a) Levels of the ASAP1 mRNA expression in primary leukocytes of healthy volunteers each 
measured in triplicate by quantitative reverse transcriptase PCR and shown relative to the 
level of expression in monocytes. CD14+ monocytes were isolated from peripheral blood of 
healthy volunteers and cultured either with M-CSF for 5 days to derive macrophages or with 
GM-CSF and IL-4 for 6 days to derive DCs. DCs were infected with live M. bovis BCG at 
multiplicity of infection 3:1 for 24 hours. Horizontal bars show mean levels. P-values were 
calculated using two-tailed Student T test. Unadjusted P-values are shown.
(b) Box plot showing the level of reduction of ASAP1 mRNA expression in DCs after M. 
tuberculosis infection for 65 subjects with different rs10956514 genotypes, 23 (AA), 30 
(AG) and 12 (GG). The bold line in the boxplot is the median; the whiskers are 1.5 IQR 
away from the first and third quartiles. Data are from ref 23 after adjustment for 5 and 8 
principle components in non-infected and infected DCs, respectively (see Methods).
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Figure 3. In DCs, the ASAP1 protein is partly associated with podosomes and its depletion leads 
to impaired matrix degradation and migration
(a) Confocal microscopy showing ASAP1 (green), actin (red), vinculin (blue) and nuclei 
(white) in DCs derived from monocytes of a healthy volunteer. Podosomes are structures 
characterized by the actin core (visible as red dots) surrounded by other proteins. Boxed area 
is shown in grayscale enlarged on the right. Scale bar represents 7.5μm.
(b) Representative confocal microscopy images (left panel) showing monocyte-derived DCs 
treated with either ASAP1 or control siRNA and seeded on FITC-conjugated gelatine (green) 
for 4 hours. The cells were stained to visualize actin (phalloidin-red) and nuclei (DAPI-
blue). White arrows show examples of the DAPI-stained nuclei of cells that do not degrade 
matrix. Scale bar represents 50μm.
In the same experiment cell lysates were collected for western blotting and probed with anti-
ASAP1 and anti-actin antibodies (right panel) to assess knockdown efficiency.
Area of degradation of the FITC-conjugated gelatine matrix by DCs (lower panel). In total 
394 and 317 DCs treated with either ASAP1 or control siRNA, respectively, were counted in 
4 independent experiments.
(c) Migration velocity of DCs in a Dunn chamber. In total 162 and 186 DCs treated with 
either ASAP1 or control siRNA, respectively, were tracked in 5 independent experiments.
Graphs show mean values ± SEM. P-values were calculated using two-tailed Student T test. 
Unadjusted P-values are shown.
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Table 1
Association between the ASAP1 gene polymorphisms and tuberculosis in the Russian 
datasets
rs1017281 rs10956514 rs1469288 rs17285138 rs2033059 rs4733781 rs12680942
Alleles (min./maj.) A/G G/A A/G A/T T/C C/A G/A
MAF (cont., cases) 35.7, 32.2 35.8, 32.3 31.5, 28.0 31.5, 28.3 31.3, 27.7 31.4, 27.8 31.2, 27.8
Set 1 (GWAS set re-typed)
n cont. 5,526 5,503 5,346 5,494 5,266 5,533 5,369
n cases 5,466 5,425 5,272 5,420 5,416 5,457 5,314
P-value 3.7 × 10−08 1.9 × 10−08 1.4 × 10−08 5.6 × 10−08 1.6 × 10−09 3.6 × 10−09 7.6 × 10−09
OR a 0.85 0.85 0.84 0.85 0.83 0.84 0.84
95% CI 0.81-0.90 0.80-0.90 0.79-0.89 0.80-0.90 0.79-0.88 0.79-0.89 0.79-0.89
Set 2 (follow-up)
n cont. 2,538 2,535 2,390 2,717 2,692 2,549 2,522
n cases 970 971 897 1,048 1,038 975 1,030
P-value 6.6 × 10−03 3.5 × 10−03 2.3 × 10−02 2.2 × 10−02 1.7 × 10−02 7.8 × 10−03 3.5 × 10−02
OR a 0.85 0.84 0.87 0.88 0.87 0.85 0.88
95% CI 0.76-0.96 0.75-0.95 0.77-0.98 0.78-0.98 0.78-0.98 0.76-0.96 0.79-0.99
Sets 1 and 2 combined
n cont. 8,064 8,038 7,736 8,211 7,958 8,082 7,891
n cases 6,436 6,396 6,169 6,468 6,454 6,432 6,344
P-value 3.7 × 10−10 1.0 × 10−10 1.1 × 10−10 3.3 × 10−09 4.3 × 10−11 2.6 × 10−11 4.1 × 10−10
OR a 0.85 0.85 0.84 0.86 0.84 0.84 0.85
95% CI 0.81-0.90 0.81-0.89 0.80-0.89 0.82-0.90 0.80-0.89 0.80-0.88 0.81-0.89
PPP 0.030 0.108 0.118 0.004 0.271 0.436 0.033
cont. – controls; min. – minor; maj. – major; MAF – minor allele frequency; OR – odds ratio; 95% CI – 95% confidence interval; PPP - proportion 
of posterior probability, SNPs with PPP > 0.05 are shown in bold.
aORs for minor alleles are shown
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